Akula Annapurna

Summary

Country: India

Publications

  1. ncbi Cardioprotective actions of two bioflavonoids, quercetin and rutin, in experimental myocardial infarction in both normal and streptozotocin-induced type I diabetic rats
    Akula Annapurna
    University College of Pharmaceutical Sciences, Andhra University, Visakhapatnam, India
    J Pharm Pharmacol 61:1365-74. 2009
  2. ncbi Biochemical, histological and echocardiographic changes during experimental cardiomyopathy in STZ-induced diabetic rats
    A Akula
    Pharmacology Division, Department of Pharmaceutical Sciences, Andhra University, Visakhapatnam, Andhra Pradesh, India
    Pharmacol Res 48:429-35. 2003
  3. ncbi Studies on the involvement of bradykinin using enalapril and 2-mercaptoethanol in ischemia-reperfusion induced myocardial infarction in albino rats
    A Akula
    Pharmacology Division, Department of Pharmaceutical Sciences, Andhra University, Visakhapatnam, Andhra Pradesh, India
    Pharmazie 58:906-9. 2003
  4. ncbi The influence of sulindac on diabetic cardiomyopathy: a non-invasive evaluation by Doppler echocardiography in streptozotocin-induced diabetic rats
    Kota M Krishna
    Pharmacology Division, Department of Pharmaceutical Sciences, Andhra University, Visakhapatnam 530003, Andhra Pradesh, India
    Vascul Pharmacol 43:91-100. 2005
  5. ncbi Infarct size limiting effect of apstatin alone and in combination with enalapril, lisinopril and ramipril in rats with experimental myocardial infarction
    K K Veeravalli
    Pharmacology Division, Department of Pharmaceutical Sciences, Andhra University, Visakhapatnam 530 003, Andhra Pradesh, India
    Pharmacol Res 48:557-63. 2003
  6. ncbi Partial reversal by rutin and quercetin of impaired cardiac function in streptozotocin-induced diabetic rats
    Kota M Krishna
    Pharmacology Division, Department of Pharmaceutical Sciences, Andhra University, Visakhapatnam, Pradesh, India
    Can J Physiol Pharmacol 83:343-55. 2005
  7. ncbi Studies on the signal cascade mechanism mediating the cardioprotective actions of bradykinin
    A Akula
    Pharmacology Division, Department of Pharmaceutical Sciences, Andhra University, Visakhapatnam, Andhra Pradesh, India
    Pharmazie 57:332-6. 2002
  8. ncbi Involvement of nitric oxide and prostaglandin pathways in the cardioprotective actions of bradykinin in rats with experimental myocardial infarction
    K K Veeravalli
    Pharmacology Division, Department of Pharmaceutical Sciences, Andhra University, Visakhapatnam 530-003, Andhra Pradesh, India
    Pharmacol Res 49:23-9. 2004
  9. ncbi Anti-atherosclerotic effect of atorvastatin and clopidogrel alone and in combination in rats
    Martha Srinivas
    Pharmacology Division, University College of Pharmaceutical Sciences, Andhra University, Visakhapatnam 530 003, India
    Indian J Exp Biol 46:698-703. 2008
  10. ncbi Therapeutic potential of sulindac against ischemia-reperfusion-induced myocardial infarction in diabetic and nondiabetic rats
    Akula Annapurna
    Department of Pharmacology, University College of Pharmaceutical Sciences, Andhra University, Visakhapatnam 530 003, Andhra Pradesh, India
    Exp Clin Cardiol 13:66-70. 2008

Collaborators

  • A Akula
  • K K Veeravalli
  • Kota M Krishna
  • M K Kota
  • Martha Srinivas
  • Gopisetty S Gopal
  • Veeravalli K Kumar
  • Kalagara Madan
  • Gomedhikam J Prakash
  • Chitrapu R V Chalam
  • K V Routhu
  • Yellu Narsimha Reddy
  • R V Chitrapu
  • S G Gopisetty
  • J P Gomedhikam
  • M Kalagara
  • S Kalagara
  • S Potharaju

Detail Information

Publications10

  1. ncbi Cardioprotective actions of two bioflavonoids, quercetin and rutin, in experimental myocardial infarction in both normal and streptozotocin-induced type I diabetic rats
    Akula Annapurna
    University College of Pharmaceutical Sciences, Andhra University, Visakhapatnam, India
    J Pharm Pharmacol 61:1365-74. 2009
    ..We attempted to evaluate the cardioprotective actions of quercetin and rutin in ischaemia-reperfusion-induced myocardial infarction in both normal and diabetic rats...
  2. ncbi Biochemical, histological and echocardiographic changes during experimental cardiomyopathy in STZ-induced diabetic rats
    A Akula
    Pharmacology Division, Department of Pharmaceutical Sciences, Andhra University, Visakhapatnam, Andhra Pradesh, India
    Pharmacol Res 48:429-35. 2003
    ....
  3. ncbi Studies on the involvement of bradykinin using enalapril and 2-mercaptoethanol in ischemia-reperfusion induced myocardial infarction in albino rats
    A Akula
    Pharmacology Division, Department of Pharmaceutical Sciences, Andhra University, Visakhapatnam, Andhra Pradesh, India
    Pharmazie 58:906-9. 2003
    ....
  4. ncbi The influence of sulindac on diabetic cardiomyopathy: a non-invasive evaluation by Doppler echocardiography in streptozotocin-induced diabetic rats
    Kota M Krishna
    Pharmacology Division, Department of Pharmaceutical Sciences, Andhra University, Visakhapatnam 530003, Andhra Pradesh, India
    Vascul Pharmacol 43:91-100. 2005
    ..Our results show for the first time that sulindac has a cardioprotective activity as this agent prevented the development of left ventricular dysfunction in STZ-induced diabetic rats in the 12-week chronic study...
  5. ncbi Infarct size limiting effect of apstatin alone and in combination with enalapril, lisinopril and ramipril in rats with experimental myocardial infarction
    K K Veeravalli
    Pharmacology Division, Department of Pharmaceutical Sciences, Andhra University, Visakhapatnam 530 003, Andhra Pradesh, India
    Pharmacol Res 48:557-63. 2003
    ..Infarct size reduction obtained with the combined inhibition came to normal with the prior administration of B2 bradykinin antagonist HOE140 suggests the involvement of bradykinin in the cardioprotective actions of apstatin...
  6. ncbi Partial reversal by rutin and quercetin of impaired cardiac function in streptozotocin-induced diabetic rats
    Kota M Krishna
    Pharmacology Division, Department of Pharmaceutical Sciences, Andhra University, Visakhapatnam, Pradesh, India
    Can J Physiol Pharmacol 83:343-55. 2005
    ....
  7. ncbi Studies on the signal cascade mechanism mediating the cardioprotective actions of bradykinin
    A Akula
    Pharmacology Division, Department of Pharmaceutical Sciences, Andhra University, Visakhapatnam, Andhra Pradesh, India
    Pharmazie 57:332-6. 2002
    ..The results are further suggesting the involvement of both prostaglandins and nitric oxide pathways in the cardioprotective actions of bradykinin...
  8. ncbi Involvement of nitric oxide and prostaglandin pathways in the cardioprotective actions of bradykinin in rats with experimental myocardial infarction
    K K Veeravalli
    Pharmacology Division, Department of Pharmaceutical Sciences, Andhra University, Visakhapatnam 530-003, Andhra Pradesh, India
    Pharmacol Res 49:23-9. 2004
    ....
  9. ncbi Anti-atherosclerotic effect of atorvastatin and clopidogrel alone and in combination in rats
    Martha Srinivas
    Pharmacology Division, University College of Pharmaceutical Sciences, Andhra University, Visakhapatnam 530 003, India
    Indian J Exp Biol 46:698-703. 2008
    ..No specific advantage was seen with combined treatment of atorvastatin and clopidogrel, moreover the advantages seen with independent drug administration also reduced with combined treatment...
  10. ncbi Therapeutic potential of sulindac against ischemia-reperfusion-induced myocardial infarction in diabetic and nondiabetic rats
    Akula Annapurna
    Department of Pharmacology, University College of Pharmaceutical Sciences, Andhra University, Visakhapatnam 530 003, Andhra Pradesh, India
    Exp Clin Cardiol 13:66-70. 2008
    ..Previous studies have found sulindac to have inhibitory and anti-inflammatory effects on aldose reductase. The use of aldose reductase inhibitors for the protection of ischemic myocardium is still in an exploratory state...